Big Pharma’s Big Misstep: Price Hikes That Prove They’re Out of Touch
<p>Let’s be clear: research and development costs money. Innovative medication takes time, talent, and resources. But while acknowledging these realities, we can’t ignore the staggering numbers. Across the industry, hundreds of drug prices are set to rise, some by as much as 9%. Insulin, a life-saving medication for millions with diabetes, is a prime offender, with Sanofi, despite recent pledges, joining the price-hike chorus. These increases come during a global cost-of-living crisis, leaving patients facing agonizing choices: refill prescriptions and risk financial hardship or forgo medication and risk their health.</p>
<p><a href="https://richardameyer.medium.com/big-pharmas-big-misstep-price-hikes-that-prove-they-re-out-of-touch-3154e7d7c7a7"><strong>Visit Now</strong></a></p>